Perinatal depression affects 10-15% of pregnant and postpartum individuals, with detrimental impacts on both parent and infant. In response to this, our department developed a perinatal consultation line for providers, PAL for Moms, to increase access to specialty perinatal psychiatric expertise and care. The purpose of the Evaluating Lifeline4Moms (ELM) is to assess comparative effectiveness of PAL for Moms and other perinatal psychiatry access and referral programs in addressing maternal depression.
As a community-engaged research endeavor, ELM has convened
patient advocates, policy experts, and perinatal clinicians, who oversee the
study as partners and advisors. Over a period of three years, the research team
will characterize the components, implementation timelines, and state policy
contexts of access and referral programs; evaluate the reach and implementation
of these programs; and examine the comparative effects on access to and quality
of mental health treatment among Medicaid-insured perinatal individuals.
Most adults in the US experience a traumatic event at some point in their
lives. Trauma is linked to the development of mental health disorders, increased
suicidality, work and relationship impairment and increased physical health
conditions. Effective treatments exist, but many people don’t receive these
treatments because of a lack of providers who are trained in evidence-based,
trauma-focused treatment, especially those in rural or underserved areas.
This project aims to build, implement and test an ECHO (Extension for
Community Healthcare Outcomes) model for disseminating evidence-based,
trauma-focused care, both psychotherapy and pharmacotherapy approaches, to
providers working with underserved communities in Washington state. The team
will evaluate the impact and reach of the training model, with the goal of
expanding the ECHO approach to improve trauma-informed mental health care
throughout Washington.
The Stepped Care for Opioid Use Disorder Train-the-Trainer (SCOUTT) program is a national VA initiative which aims to improve access to treatment medications for opioid use disorder (OUD) in primary care, pain management, and mental health clinics. The Seattle CESATE is conducting ongoing evaluations of SCOUTT to understand providers’ perspectives on the initiative and the outcomes for Veteran participants. Project aims also include to: assess patient retention in and compliance with SCOUTT, assess changes in number of waivered and prescribing providers, retention in and compliance with stepped care, and identify barriers and facilitators to implementing, sustaining and spreading OUD care.
AIMS Center staff and faculty are working with primary care and behavioral health partners in each ACH to train staff and providers on whole person care strategies. This includes training primary care practices to adopt the Collaborative Care model and/or Bree Behavioral Health Integration Recommendations and training community behavioral health agencies to address the physical health needs of their clients.
Through partnership with New York-based practice coaches as well as its own expert clinician trainers, the AIMS Center supports effective practice change for behavioral health integration, planning for implementation of the Collaborative Care Model (CoCM), and providing behavioral health clinician training and technical support for New York Medicaid primary care providers.
The RMHII is a partnership between the AIMS Center and Premera Blue Cross to expand access to evidence-based mental health treatment in rural areas. The AIMS Center will lead clinic selection, training, technical assistance, and practice coaching for up to 30 primary care clinics in rural Washington and Alaska.
Several recent studies have found that for evidence-based psychosocial interventions (EBPIs) to be delivered more effectively, sustained quality, ongoing supervision, and guidance is critical.
This study will develop an electronic support tool to support quality delivery of PST that is based on clinician feedback. We hypothesize that supporting clinician delivery of EBPIs will result in enhanced quality of treatment and better patient outcomes.
